Testing effectiveness (Phase 2)Study completedNCT03064490
What this trial is testing
Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED)
Who this might be right for
Locally Advanced Esophageal and Gastric Cancers (EGC)
Duke University 35